News and insights
223 81 Lund, Sverige
+46 46-15 21 00
©Copyright 2022 CLS AB. All rights reserved.
Today, 9th of June, our CEO Dan J. Mogren presented CLS at BioStock Life Science Spring Summit. The presentation covers the rationale and strengths of CLS product portfolio, our market segments and their huge potential, and provides some insights to what the future holds for CLS.
Welcome to watch the full event here:
CLS is a medtech company that develops and sells tools for minimally invasive treatment based on image-guided laser ablation, with focus on:
So far more than 250 treatments have been completed with the first generation TRANBERG® products. The second generation of TRANBERG® brings new features to control and monitor the treatment and is now undergoing investigator-initiated clinical studies in Europe and the USA.
Welcome to Clinical Laserthermia Systems.
Please note that all our products and indications are not yet approved in all markets. Don’t hesitate to contact us for up-to-date market approvals in your area!
Please choose your country or region